Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Management of drooling in children: a survey of UK paediatricians' clinical practice.

Parr JR, Buswell CA, Banerjee K, Fairhurst C, Williams J, O'Hare A, Pennington L; British Academy of Childhood Disability Drooling Study Development Group.

Child Care Health Dev. 2012 Mar;38(2):287-91. doi: 10.1111/j.1365-2214.2011.01213.x. Epub 2011 Mar 11.

PMID:
21392056
2.

The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.

Parr JR, Weldon E, Pennington L, Steen N, Williams J, Fairhurst C, O'Hare A, Lodh R, Colver A.

Trials. 2014 Feb 17;15:60. doi: 10.1186/1745-6215-15-60.

3.

Glycopyrrolate for chronic drooling in children.

Eiland LS.

Clin Ther. 2012 Apr;34(4):735-42. doi: 10.1016/j.clinthera.2012.02.026. Epub 2012 Mar 23. Review.

PMID:
22445330
4.

Preliminary study of glycopyrrolate in the management of drooling.

Stern LM.

J Paediatr Child Health. 1997 Feb;33(1):52-4.

PMID:
9069045
5.

Management of drooling in disabled patients with scopolamine patches.

Mato A, Limeres J, Tomás I, Muñoz M, Abuín C, Feijoo JF, Diz P.

Br J Clin Pharmacol. 2010 Jun;69(6):684-8. doi: 10.1111/j.1365-2125.2010.03659.x.

6.

Glycopyrrolate treatment of chronic drooling.

Blasco PA, Stansbury JC.

Arch Pediatr Adolesc Med. 1996 Sep;150(9):932-5.

PMID:
8790123
7.

Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.

Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.

Pediatrics. 2004 Sep;114(3):620-7.

PMID:
15342830
8.

Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling.

van der Burg JJ, Jongerius PH, van Limbeek J, van Hulst K, Rotteveel JJ.

Eur J Pediatr. 2006 Jan;165(1):37-41. Epub 2005 Sep 20.

PMID:
16172877
9.

Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.

Garnock-Jones KP.

Paediatr Drugs. 2012 Aug 1;14(4):263-9. doi: 10.2165/11208120-000000000-00000. Review.

PMID:
22646067
10.

The management of drooling in adults with neurological conditions.

Squires N, Wills A, Rowson J.

Curr Opin Otolaryngol Head Neck Surg. 2012 Jun;20(3):171-6. doi: 10.1097/MOO.0b013e32835328ec. Review.

PMID:
22487791
11.

[Drooling therapy in children with neurological disorders].

Táboas-Pereira MA, Paredes-Mercado C, Alonso-Curcó X, Badosa-Pagès J, Muchart J, Póo P.

Rev Neurol. 2015 Jul 16;61(2):66-70. Spanish.

PMID:
26156441
12.

Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.

Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS.

Dev Med Child Neurol. 2008 Feb;50(2):123-8. doi: 10.1111/j.1469-8749.2007.02010.x.

13.

A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling.

Jongerius PH, van Tiel P, van Limbeek J, Gabreëls FJ, Rotteveel JJ.

Arch Dis Child. 2003 Oct;88(10):911-4. Review.

14.

Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.

Van der Burg JJ, Jongerius PH, Van Hulst K, Van Limbeek J, Rotteveel JJ.

Dev Med Child Neurol. 2006 Feb;48(2):103-7.

15.
16.

Surgical management of drooling: clinical and caregiver satisfaction outcomes.

Stamataki S, Behar P, Brodsky L.

Int J Pediatr Otorhinolaryngol. 2008 Dec;72(12):1801-5. doi: 10.1016/j.ijporl.2008.08.012. Epub 2008 Oct 9.

PMID:
18848362
17.

Oral glycopyrrolate alleviates drooling in a patient with tongue cancer.

Olsen AK, Sjøgren P.

J Pain Symptom Manage. 1999 Oct;18(4):300-2.

PMID:
10534970
18.

Prescribing of psychotropic medication to the intellectually disabled by community paediatricians - a survey.

Elliott SJ, Haider BB.

Child Care Health Dev. 2009 Nov;35(6):826-31. doi: 10.1111/j.1365-2214.2008.00932.x. Epub 2009 May 4.

PMID:
19438877
19.

Transdermal scopolamine for reduction of drooling in developmentally delayed children.

Lewis DW, Fontana C, Mehallick LK, Everett Y.

Dev Med Child Neurol. 1994 Jun;36(6):484-6.

PMID:
7516297
20.

Botulinum toxin A as a treatment for excessive drooling in children.

Bothwell JE, Clarke K, Dooley JM, Gordon KE, Anderson R, Wood EP, Camfield CS, Camfield PR.

Pediatr Neurol. 2002 Jul;27(1):18-22.

PMID:
12160968

Supplemental Content

Support Center